• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

30例多发性骨髓瘤患者的细胞遗传学研究:采用小型化核型分析方法比较细胞因子刺激或未刺激的3天和6天骨髓培养物

Cytogenetic study of 30 patients with multiple myeloma: comparison of 3 and 6 day bone marrow cultures stimulated or not with cytokines by using a miniaturized karyotypic method.

作者信息

Brigaudeau C, Trimoreau F, Gachard N, Rouzier E, Jaccard A, Bordessoule D, Praloran V

机构信息

Laboratoire d'Hematologie, CHRU de Limoges, France.

出版信息

Br J Haematol. 1997 Mar;96(3):594-600. doi: 10.1046/j.1365-2141.1997.d01-2073.x.

DOI:10.1046/j.1365-2141.1997.d01-2073.x
PMID:9054668
Abstract

Cytogenetics in multiple myeloma (MM) cases are generally difficult to perform due to the low proliferation index of malignant plasma cells (PC) in most cases. Although IL-6 and GM-CSF stimulate the in vitro proliferation of malignant plasma cells, their usefulness for improving cytogenetic results in multiple myeloma patients remains questionable, because results which compare various culture conditions in a sufficient number of patients are not available. By using a miniaturized karyotypic method, we compared in 30 multiple myeloma patients the number and percentage of clonal abnormal mitoses obtained from 3 and 6 d bone marrow cultures performed without or with two combinations of cytokines: IL-6 + GM-CSF or IL-6 + GM-CSF + IL-2 + IL-4 + TNFalpha. The percentage of patients with an abnormal karyotype, which varied with the Durie and Salmon stage of the disease, as well as the type of numerical and structural karyotypic abnormalities that we detected, were in agreement with published results. The detection of clonal karyotypic abnormalities was better after 3d of culture without cytokine than in all other culture conditions. The higher percentage of patients at all stages of MM with an abnormal karyotype in our study (76.6%) than in previous ones (20% to 60%) is largely explained by the large number of mitoses analysed in six different culture conditions due to the use of a miniaturized karyotypic method.

摘要

在多数多发性骨髓瘤(MM)病例中,由于恶性浆细胞(PC)的增殖指数较低,细胞遗传学分析通常很难进行。尽管白细胞介素-6(IL-6)和粒细胞巨噬细胞集落刺激因子(GM-CSF)能刺激恶性浆细胞的体外增殖,但它们对改善多发性骨髓瘤患者细胞遗传学结果的有效性仍存在疑问,因为尚无足够数量患者在不同培养条件下的对比结果。通过使用一种小型化核型分析方法,我们在30例多发性骨髓瘤患者中比较了在无细胞因子或添加两种细胞因子组合(IL-6 + GM-CSF或IL-6 + GM-CSF + IL-2 + IL-4 +肿瘤坏死因子α(TNFα))的情况下,3天和6天骨髓培养所获得的克隆性异常有丝分裂的数量和百分比。核型异常患者的百分比随疾病的Durie和Salmon分期而变化,我们检测到的数量和结构核型异常类型与已发表的结果一致。在无细胞因子培养3天后,克隆性核型异常的检测效果优于所有其他培养条件。本研究中处于MM各阶段的核型异常患者百分比(76.6%)高于以往研究(20%至60%),这在很大程度上是由于使用了小型化核型分析方法,在六种不同培养条件下分析了大量有丝分裂。

相似文献

1
Cytogenetic study of 30 patients with multiple myeloma: comparison of 3 and 6 day bone marrow cultures stimulated or not with cytokines by using a miniaturized karyotypic method.30例多发性骨髓瘤患者的细胞遗传学研究:采用小型化核型分析方法比较细胞因子刺激或未刺激的3天和6天骨髓培养物
Br J Haematol. 1997 Mar;96(3):594-600. doi: 10.1046/j.1365-2141.1997.d01-2073.x.
2
Improved cytogenetic analysis of bone marrow plasma cells after cytokine stimulation in multiple myeloma: a report on 46 patients.细胞因子刺激后多发性骨髓瘤患者骨髓浆细胞的细胞遗传学分析改进:46例患者报告
Br J Haematol. 1993 Aug;84(4):743-5. doi: 10.1111/j.1365-2141.1993.tb03155.x.
3
Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis.多发性骨髓瘤细胞遗传学的改善:一项针对151例患者的研究,其中包括117例诊断时的患者。
Blood. 1995 May 1;85(9):2490-7.
4
Cytogenetic features of multiple myeloma: impact of gender, age, disease phase, culture time, and cytokine stimulation.多发性骨髓瘤的细胞遗传学特征:性别、年龄、疾病分期、培养时间和细胞因子刺激的影响
Eur J Haematol. 2002 Jun;68(6):345-53. doi: 10.1034/j.1600-0609.2002.00724.x.
5
Interleukin-3 plus interleukin-6 may improve chromosomal analysis of multiple myeloma: cytologic and cytogenetic evidence in thirty-four patients.白细胞介素-3加白细胞介素-6可能改善多发性骨髓瘤的染色体分析:34例患者的细胞学和细胞遗传学证据
Cancer Genet Cytogenet. 1996 Sep;90(2):171-5. doi: 10.1016/s0165-4608(96)00129-x.
6
Cytogenetic study in multiple myeloma at diagnosis: comparison of two techniques.多发性骨髓瘤诊断时的细胞遗传学研究:两种技术的比较
Br J Haematol. 1995 Jul;90(3):619-24. doi: 10.1111/j.1365-2141.1995.tb05593.x.
7
IL-4 improves the detection of cytogenetic abnormalities in multiple myeloma and increases the proportion of clonally abnormal metaphases.白细胞介素-4可改善多发性骨髓瘤细胞遗传学异常的检测,并增加克隆性异常中期相的比例。
Br J Haematol. 1998 Oct;103(1):163-7. doi: 10.1046/j.1365-2141.1998.00951.x.
8
[The cytogenetic and molecular genetic study of 81 multiple myeloma patients].[81例多发性骨髓瘤患者的细胞遗传学和分子遗传学研究]
Zhonghua Nei Ke Za Zhi. 2011 Dec;50(12):1039-42.
9
Cytogenetics in multiple myeloma and plasma cell leukemia: simultaneous cytogenetic and cytologic studies in 51 patients.多发性骨髓瘤和浆细胞白血病的细胞遗传学:51例患者的细胞遗传学与细胞学同步研究
Ann Hematol. 1992 Aug;65(2):88-90. doi: 10.1007/BF01698136.
10
99mTc-sestamibi imaging and bone marrow karyotyping in the assessment of multiple myeloma and MGUS.99mTc-司他米比显像和骨髓核型分析在多发性骨髓瘤和意义未明的单克隆丙种球蛋白血症评估中的应用
Nucl Med Commun. 2008 Jun;29(6):535-41. doi: 10.1097/MNM.0b013e3282f5e5df.

引用本文的文献

1
Chromothripsis in Treatment Resistance in Multiple Myeloma.多发性骨髓瘤治疗耐药中的染色体碎裂现象
Genomics Inform. 2017 Sep;15(3):87-97. doi: 10.5808/GI.2017.15.3.87. Epub 2017 Sep 28.